Chengdang Xu
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Oncology
- Biomedical Engineering
- Co-authors
- Denglong WuWei LeGang WuZhendong XiangShengsong HuangXinan WangBo LiuXi Chen
- Topics
- Prostate Cancer Treatment and Research (14 papers)Cancer, Lipids, and Metabolism (5 papers)Ferroptosis and cancer prognosis (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Cancer ResearchFrontiers in Immunology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Chengdang Xu
34 papers receiving 451 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 265
- Cancer Research 211
- Pulmonary and Respiratory Medicine 146
- Oncology 50
- Biomedical Engineering 49
Countries citing papers authored by Chengdang Xu
This map shows the geographic impact of Chengdang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengdang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengdang Xu more than expected).
Fields of papers citing papers by Chengdang Xu
This network shows the impact of papers produced by Chengdang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengdang Xu. The network helps show where Chengdang Xu may publish in the future.
Co-authorship network of co-authors of Chengdang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Chengdang Xu. A scholar is included among the top collaborators of Chengdang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengdang Xu. Chengdang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 24 | |
| 8 | 4 | |
| 9 | 18 | |
| 10 | 1 | |
| 11 | 20 | |
| 12 | 13 | |
| 13 | 4 | |
| 14 | 8 | |
| 15 | 7 | |
| 16 | 24 | |
| 17 | 12 | |
| 18 | 23 | |
| 19 | 27 | |
| 20 | 41 |
About Chengdang Xu
Chengdang Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Biophysics, having authored 34 papers that have together received 455 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Cancer, Lipids, and Metabolism (5 papers) and Ferroptosis and cancer prognosis (5 papers). The work is most often cited by research in Cancer Research (211 citations), Drug Discovery (1 citation) and Pulmonary and Respiratory Medicine (146 citations). Chengdang Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Denglong Wu, Wei Le, Gang Wu, Zhendong Xiang, Shengsong Huang, Xinan Wang, Bo Liu, Xi Chen, Junjie Ma and Xinan Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.